HealthEquity Reports Q2 Revenue Beat, Provides Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY) Following Beat and Raise
September 7, 2022 8:22 AM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $80.00 price target on HealthEquity, Inc (NASDAQ: HQY) following Q2 beat and raise.
The analyst commented, "2Q beat & raise was driven by ongoing momentum in HSA acct/asset growth and higher HSA yield -owing... More
